Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$5.8MFederal grants as PI8 awards
0Patents grantedNone matched
319Papers16,786 citations
Federal awards and patents by year
AwardsPatents
8 awards · $5.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 1, 2023 | NIH | STTR Phase II Robust Predictor of Colon Cancer Risk | $1.0M | Morgan and Mendel Genomics, Inc. |
| Aug 16, 2022 | NIH | STTR Phase II Robust Predictor of Colon Cancer Risk | $2.0M | Morgan and Mendel Genomics, Inc. with ALBERT EINSTEIN COLLEGE OF MEDICINE |
| Jan 19, 2022 | NIH | STTR Phase II Robust Predictor of Breast Cancer Risk | $160K | Morgan and Mendel Genomics, Inc. |
| Aug 31, 2021 | NIH | STTR Phase II Robust Predictor of Breast Cancer Risk | $1.0M | Morgan and Mendel Genomics, Inc. |
| Jul 17, 2020 | NIH | STTR Phase II Robust Predictor of Breast Cancer Risk | $992K | Morgan and Mendel Genomics, Inc. |
| Sep 13, 2018 | NIH | STTR Phase I Robust Predictor of Colon Cancer Risk | $300K | Morgan and Mendel Genomics, Inc. with MORGAN AND MENDEL GENOMICS, INC. |
| Sep 12, 2018 | NIH | STTR Phase I Robust Predictor of Breast Cancer Risk | $2K | Morgan and Mendel Genomics, Inc. |
| Sep 20, 2017 | NIH | STTR Phase I Robust Predictor of Breast Cancer Risk | $302K | Morgan and Mendel Genomics, Inc. with MORGAN AND MENDEL GENOMICS, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#228
Awards as PI#216
Patents#505
Companies
- Morgan and Mendel Genomics, Inc.Linked by awards · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.